Signaling pathways of β-cell death in type 2 diabetes mellitus: the role of innate immunity

Código QR

Signaling pathways of β-cell death in type 2 diabetes mellitus: the role of innate immunity

Type 2 diabetes mellitus (T2DM) is a multifactorial metabolic disease, the development of which is mediated by both genetic disorders and various intracellular and extracellular molecular processes. One of the main pathogenetic mechanisms for the development of T2DM is a progressive decrease in the...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zilya. A. Kalmykovа, Irina V. Kononenko, Olga M. Smirnova, Marina Vladimirovna Shestakova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2020
Materias:	type 2 diabetes mellitus β-cell mechanisms of cell damage pyroptosis inflammasomes immunity Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/3a607b019d4648998663e1190e71cc06
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

MiR-17-5p Inhibits TXNIP/NLRP3 Inflammasome Pathway and Suppresses Pancreatic β-Cell Pyroptosis in Diabetic Mice
por: Sijun Liu, et al.
Publicado: (2021)

Diabetes mellitus due to biliary recurrent pancreatitis. Case report
por: Elena Alexandrovna Kharlashina, et al.
Publicado: (2011)

Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19
por: Z. A. Kalmykova, et al.
Publicado: (2020)

Endothelial progenitor cells in diabetes complications
por: Marina Cergeevna Michurova, et al.
Publicado: (2015)

Antihyperglycemic therapy in patients with type 2 diabetes mellitus and ischaemic heart disease: management during acute period of myocardial infarction and interventional procedures
por: Olga Mikhailovna Smirnova, et al.
Publicado: (2012)

Targeting risk factors: a feasible way for prevention of vascular complications in type 2 diabetes mellitus
por: Irina Vladimirovna Kononenko, et al.
Publicado: (2012)

Glucagon and alpha-cells as a novel therapeutic target in the management of diabetes mellitus
por: Nina Alexandrovna Petunina, et al.
Publicado: (2013)

Significance of the results of genome-wide association studies for primary prevention of type 2 diabetes mellitus and its complications. Personalised approach
por: Ivan Ivanovich Dedov, et al.
Publicado: (2014)

Modern possibilities for using stem cells in diabetes mellitus
por: Ivan Ivanovich Dedov, et al.
Publicado: (2014)

Gasdermin D deficiency attenuates arthritis induced by traumatic injury but not autoantibody-assembled immune complexes
por: Tong Yang, et al.
Publicado: (2021)

Prospects for therapy aimed at restoring the beta-cell pool in patients with diabetes mellitus (review of the literature)
por: Valentina Alexandrovna Peterkova, et al.
Publicado: (2009)

Pharmacogenetics of hypoglycemic agents
por: Irina Vladimirovna Kononenko, et al.
Publicado: (2015)

Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
por: Marina Sergeevna Michurova, et al.
Publicado: (2014)

Pyroptosis: A New Insight Into Eye Disease Therapy
por: Yun Zhang, et al.
Publicado: (2021)

Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s disease
por: Wenjuan Rui, et al.
Publicado: (2021)

Genetic framework of type 2 diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2013)

bFGF and TGFbeta1 growth factors, inflammatory markers (IL-6, TNF-alpha, CRP) and advanced glycation end-products (AGE, RAGE) in patients with ischemic heart disease and type 2 diabetes mellitus
por: Ekaterina Vladimirovna Ivannikova, et al.
Publicado: (2013)

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
por: Ekaterina Viktorovna Artemova, et al.
Publicado: (2012)

Concurrent type 1 diabetes mellitus and beta-cell lymphoma in a 12 year-old child: treatment with rituximab does not changethe clinical course of diabetes
por: Aleksey Vasil'evich Kiyaev, et al.
Publicado: (2009)

Fungal cell wall components modulate our immune system
por: Benoit Briard, et al.
Publicado: (2021)

Diabetes mellitus as an economic problem in Russian Federation
por: Ivan Ivanovich Dedov, et al.
Publicado: (2016)

β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances
por: Noyonika Mukherjee, et al.
Publicado: (2021)

Cardiorenal relationships in patients with type 2 diabetes mellitus: new data of the ADVANCE study
por: Marina Vladimirovna Shestakova
Publicado: (2009)

Изучение количества циркулирующих прогениторных клеток эндотелия у больных сахарным диабетом 1 типа
por: Angelina Valerievna Sokolova, et al.
Publicado: (2015)

New prospects in the treatment of diabetes mellitus
por: Minara Shamkhalovna Shamkhalova, et al.
Publicado: (2012)

Consensus position of endocrinologists and pathologists on coding causes of death in patients with diabetes mellitus (expert opinion)
por: I. I. Dedov, et al.
Publicado: (2021)

Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease
por: Minara Shamkhalovna Shamkhalova, et al.
Publicado: (2013)

Mobilization of endothelial progenitor cells after endovascular interventions in patients with type 2 diabetes mellitus
por: Marina Sergeevna Michurova, et al.
Publicado: (2014)

PPARy - predstavitel' semeystva yadernykh steroidnykh retseptorov
por: Irina Vladimirovna Kononenko, et al.
Publicado: (2005)

Klinicheskie, immunologicheskie i geneticheskie osobennosti medlenno progressiruyushchego autoimmunnogo diabeta
por: Irina Vladimirovna Kononenko, et al.
Publicado: (2003)

New indications for exenatide therapy of type 2 diabetes mellitus
por: Olga Konstantinovna Vikulova, et al.
Publicado: (2010)

beta-cell transplantation in diabetes mellitus
por: S Pellegrini, et al.
Publicado: (2013)

Characteristics of natural history of diabetes mellitus, manifested after Cushing disease treatment
por: Elena Viktorovna Peretokina, et al.
Publicado: (2012)

Russian multicentre type 2 diabetes screening program in patients with cardiovascular disease
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2016)

An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes
por: Aroa Baragaño Raneros, et al.
Publicado: (2021)

National register of diabetes mellitus in Russian Federation.
por: Ivan Ivanovich Dedov, et al.
Publicado: (2015)

Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
por: Marina Vladimirovna Shestakova
Publicado: (2010)

Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
por: Vadim V. Genkel, et al.
Publicado: (2018)

Cardiorenal syndrome in patients with chronic kidney disease and diabetes mellitus
por: Irina Mikhailovna Kutyrina, et al.
Publicado: (2013)

The role of apoptosis in pathogenesis of type 1 diabetes mellitus
por: Elena Vladimirovna Pekareva, et al.
Publicado: (2010)